Lentiviral Vector Platform for Production of Bioengineered Recombinant Coagulation Factor VIII

Patients with hemophilia A present with spontaneous and sometimes life-threatening bleeding episodes that are treated using blood coagulation factor VIII (fVIII) replacement products. Although effective, these products have limited availability worldwide due to supply limitations and product costs,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Spencer, H Trent, Denning, Gabriela, Gautney, Richard E, Dropulic, Boro, Roy, Andre J, Baranyi, Lajos, Gangadharan, Bagirath, Parker, Ernest T, Lollar, Pete, Doering, Christopher B
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3034847/
https://ncbi.nlm.nih.gov/pubmed/21081907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.239
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia